| Abstrakt: |
A recent study conducted at Osmania University in Hyderabad, India, focused on the design and synthesis of novel triazoloquinazolin-5(3h)-one analogues as potential antitubercular agents. The research involved the testing of various compounds for their in vitro antitubercular activity, with promising results shown by specific analogues. One compound, in particular, demonstrated excellent in vitro antitubercular activity and was identified as a potential lead molecule for further development as an antitubercular agent. The study has been peer-reviewed and offers valuable insights into potential treatments for tuberculosis. [Extracted from the article] |
